SARS-CoV-2 (COVID-19)The vaccine has been developed by the Australian-owned company CSL Seqirus (CSLS) at its main UK manufacturing plant in Speke, Liverpool.
They have already been used to protect workers in Finland, where H5N1 spread amongst farmed mink last year. The Finnish government procured 10,000 doses – although only 450 people took up the offer to get jabbed.
All GNU social JP content and data are available under the